News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AbbVie (ABBV) Declares Quarterly Dividend


9/19/2013 11:05:17 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

NORTH CHICAGO, Ill., Sept. 19, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.40 per share.

The cash dividend is payable Nov. 15, 2013 to stockholders of record at the close of business on Oct. 15, 2013.

AbbVie was named to the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years. AbbVie was included as a result of the Index's change in its treatment of spin-off companies.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

Media:

Adelle Infante
(847) 938-8745

Investors:

Liz Shea
(847) 935-2211

SOURCE AbbVie



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
AbbVie
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES